Table 3 . Characteristics of pediatric Cancer patients with SSTIs, stratified by In-Hospital mortality: results of univariate analysis

Gender

 Male

4 (4.17)

92 (95.83)

0.02

0.849

 Female

5 (3.82)

126 (96.18)

Age Group

 <1 year

0 (0)

5 (100)

2.9

0.574

 1–6 years

4 (4.44)

86 (95.56)

 6–12 years

1 (1.37)

72 (98.63)

 13–18 years

4 (6.9)

54 (93.1)

 >18 years

0 (0)

1 (100)

Type of Malignancy

 Solid Tumor

1 (1.14)

87 (98.86)

3.84

0.147

 Hematologic Malignancy

8 (6.2)

121 (93.8)

 Non-malignant

0 (0)

8 (100)

Specific Diagnosis

 Leukemia

8 (8.79)

83 (91.21)

9.38

0.095

 Lymphoma

0 (0)

28 (100)

 Sarcoma

1 (2.33)

42 (97.67)

 Nervous System Tumor

0 (0)

27 (100)

 Other Tumors

0 (0)

26 (100)

 Non-malignant disorders

0 (0)

8 (100)

Febrile Neutropenia

 Negative

3 (4.55)

63 (95.45)

2.52

0.824

 Positive

6 (3.9)

148 (96.1)

Infection Site

 Limbs

4 (10.81)

33 (89.19)

1.76

0.624

 Port

0 (0)

13 (100)

 Others

0 (0)

1 (100)

 Bone and bone marrow

0 (0)

1 (100)

White Blood Cell Count*

 <500

3 (5.56)

51 (94.44)

2.78

0.734

 500–999

2 (8)

23 (92)

 1000–1499

0 (0)

12 (100)

 1500–4999

1 (1.61)

61 (98.39)

 5000–15,000

2 (4.55)

42 (95.45)

 >15,000

1 (4.35)

22 (95.65)

Culture of Infection Site

 Coagulase-negative Staphylococcus

0 (0)

12 (100)

12.71

0.24

 Acinetobacter

1 (50)

1 (50)

 Pseudomonas aeruginosa

0 (0)

7 (100)

 Klebsiella

0 (0)

4 (100)

 Citrobacter

0 (0)

1 (100)

 Staphylococcus saprophyticus

0 (0)

1 (100)

 Streptococcus viridians

0 (0)

1 (100)

 E. coli

2 (10.53)

17 (89.47)

 Non-hemolytic Streptococcus Group D

0 (0)

2 (100)

 Stenotrophomonas maltophilia

0 (0)

1 (100)

 Non-albicans Candida

1 (50)

1 (50)

Type of skin and soft tissue Infection

 Phlebitis

1 (1.49)

66 (98.51)

3.03

0.553

 Perianal Abscess

1 (3.85)

25 (96.15)

 Surgical Site Infection

2 (5.13)

37 (94.87)

 Cellulitis

5 (6.49)

72 (93.51)

 Others

0 (0)

14 (100)